EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases ( MMPs ) in liver fibrosis

Usman Sabir, Hong-Mei Gu, Da-Wei Zhang iD

Phytotherapy Research · 2023-11 · 37 (11) · 4932-4962

DOI: 10.1002/ptr.7959 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2023-07-17. Written by Usman Sabir and 2 co-authors. Institution: Department of Pediatrics and Group on the Molecular and Cell Biology of Lipids, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, A…. Major MEDLINE topics: Liver Cirrhosis, Extracellular Matrix. Cited 42 times so far (Crossref); 214 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Institute of Nutrition, Metabolism and Diabetes.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Extracellular matrix (ECM) resolution by matrix metalloproteinases (MMPs) is a well‐documented mechanism. MMPs play a dual and complex role in modulating ECM degradation at different stages of liver fibrosis, depending on the timing and levels of their expression. Increased MMP‐1 combats disease progression by cleaving the fibrillar ECM. Activated hepatic stellate cells (HSCs) increase expression of MMP‐2, ‐9, and ‐13 in different chemicals‐induced animal models, which may alleviate or worsen disease progression based on animal models and the stage of liver fibrosis. In the early stage, elevated expression of certain MMPs may damage surrounding tissue and activate HSCs, promoting fibrosis progression. At the later stage, downregulation of MMPs can facilitate ECM accumulation and disease progression. A number of phytochemicals modulate MMP activity and ECM turnover, alleviating disease progression. However, the effects of phytochemicals on the expression of different MMPs are variable and may depend on the disease models and stage, and the dosage, timing and duration of phytochemicals used in each study. Here, we review the most recent advances in the role of MMPs in the effects of phytochemicals on liver fibrogenesis, which indicates that further studies are warranted to confirm and define the potential clinical efficacy of these phytochemicals.

Subjects

MeSH terms (MEDLINE)

Liver CirrhosisExtracellular MatrixAnimalsPhytochemicalsDisease Progression

Author keywords

extracellular matrixflavonoidshepatic fibrosismatrix metalloproteinaseterpenoids

Substances

Phytochemicals

Authors and institutions

  • Department of Pediatrics and Group on the Molecular and Cell Biology of Lipids, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

ORCID profiles: Da-Wei Zhang

Funding

  • Institute of Nutrition, Metabolism and Diabetes

Cite

APA

Sabir, U., Gu, H. M., & Zhang, D. W. (2023). Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases ( MMPs ) in liver fibrosis. Phytotherapy Research, 37(11), 4932-4962. https://doi.org/10.1002/ptr.7959

Vancouver

Sabir U, Gu HM, Zhang DW. Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases ( MMPs ) in liver fibrosis. Phytotherapy Research. 2023;37(11):4932-4962. doi:10.1002/ptr.7959

BibTeX
@article{Sabir2023,
  author = {Sabir, Usman and Gu, Hong-Mei and Zhang, Da-Wei},
  title = {Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases ( MMPs ) in liver fibrosis},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {11},
  pages = {4932--4962},
  doi = {10.1002/ptr.7959}
}
Start for free →